Table 3.
Objective response rate.
| Patients, n (%) | Treatment group | Total (N = 70) |
||||||
|---|---|---|---|---|---|---|---|---|
| A (n = 9) |
B (n = 9) |
C (n = 11) |
D (n = 9) |
E (n = 13) |
F (n = 8) |
G (n = 11) |
||
| Best response | ||||||||
| Complete response | 0 | 0 | 1 (9.1) | 0 | 0 | 0 | 0 | 1 (1.4) |
| Partial response | 5 (55.6) | 5 (55.6) | 2 (18.2) | 3 (33.3) | 2 (15.4) | 3 (37.5) | 1 (9.1) | 21 (30.0) |
| Stable disease | 2 (22.2) | 2 (22.2) | 7 (63.6) | 4 (44.4) | 2 (15.4) | 2 (25.0) | 4 (36.4) | 23 (32.9) |
| Progressive disease or death | 2 (22.2) | 2 (22.2) | 0 | 2 (22.2) | 9 (69.2) | 3 (37.5) | 6 (54.5) | 24 (34.3) |
| Not evaluable | 0 | 0 | 1 (9.1) | 0 | 0 | 0 | 0 | 1 (1.4) |
| Objective response rate | 5 (55.6) | 5 (55.6) | 3 (27.3) | 3 (33.3) | 2 (15.4) | 3 (37.5) | 1 (9.1) | 22 (31.4) |